1. Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system

   • Richard W. Yee
   • Evan G. Norcom
   • Xinping C. Zhao

   OriginalPaper Pages: 511 - 518

2. Travelers’ diarrhea

   • Alexander K. C. Leung
   • William Lane M. Robson
   • H. Dele Davies

   OriginalPaper Pages: 519 - 527

3. Hyperbaric oxygen: A novel technology for modulating myocardial ischemia-reperfusion via a single drug

   • Jeysen Zivan Yogaratnam
   • Gerard Laden
   • Steve Griffin

   OriginalPaper Pages: 528 - 533

4. Prognostic factors in patients with aggressive non-Hodgkin’s lymphoma without complete response to first-line therapy

   • Suleyman Alici
   • Sevil Bavbek
   • Haluk Onat

   OriginalPaper Pages: 534 - 542

5. Congenital cranial and spinal dermal sinuses: A report of 3 cases

   • Erdal Kalkan
   • Hakan Karabagli
   • Alper Baysefer

   OriginalPaper Pages: 543 - 548

6. Effect of nateglinide on the size of LDL particles in patients with type 2 diabetes

   • Yutaka Onishi
   • Takashi Fujisawa
   • Mitsuo Maeda

   OriginalPaper Pages: 549 - 555

7. Urinary incontinence: Economic burden and new choices in pharmaceutical treatment

   • Richard Levy
   • Nancy Muller

   OriginalPaper Pages: 556 - 573

8. Totally implantable venous access devices via subclavian vein: A retrospective study of 368 oncology patients

   • Emine Ozyuvaci
   • Fikret Kutlu

   OriginalPaper Pages: 574 - 581

9. Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical setting

   • Eric R. Braverman
   • Thomas J. H. Chen
   • Kenneth Blum

   OriginalPaper Pages: 582 - 600

10. Tolerability to 1-year treatment with once-daily molsidomine in patients with stable angina

    • Roger Messin
    • Jacques Bruhwyler
    • Joseph Géczy

    OriginalPaper Pages: 601 - 614

11. Effects of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and their combination on microalbuminuria in normotensive patients with type 2 diabetes

    • Aysegul Atmaca
    • Olcay Gedik

    OriginalPaper Pages: 615 - 622

12. Esophageal actinomycosis

    • Fu-Tsan Chou
    • Ken-Sheng Cheng
    • I-Ping Chiang

    OriginalPaper Pages: 623 - 626

13. Why the most potent toxin may heal anal fissure

    • Mariusz Madalinski
    • Zygmunt Chodorowski

    OriginalPaper Pages: 627 - 634

14. Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-α in bone marrow and peripheral blood of patients with multiple myeloma

    • Ismail Oguz Kara
    • Berksoy Sahin
    • Cagatay Unsal

    OriginalPaper Pages: 635 - 645

15. Open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors

    • Numan Konuk
    • Nuray Atasoy
    • Ömer Akay

    OriginalPaper Pages: 646 - 654

16. C-reactive protein and monitoring the activity of Crohn’s disease

    • Levent Filik
    • Ulku Dagli
    • Aysel Ulker

    OriginalPaper Pages: 655 - 662